Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Phathom Pharmaceuticals, Inc. (PHAT)
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Gross Profit: $14 million, with a gross margin of 86%, an increase of about 440 basis points over last quarter. R&D Expenses: Non-GAAP R&D spend of $7.4 million, a 32% decrease compared to Q3 2023. SG&A Expenses: Non-GAAP expenses of $71.8 million for Q3 2024, with advertising costs of approximately $17.5 million. Net Loss: Non-GAAP adjusted net loss of $67.9 million or $1.05 loss per share for Q3 2024. Cash and Cash Equivalents: $335 million as of September 30, 2024. Prescriptions Filled: Over 143,000 prescriptions filled from launch through October 25th, with approximately 69,000 filled in Q3 2024. Commercial Coverage: VOQUEZNA's total covered population now captures over an estimated 120 million people or more than 80% of all US commercial lives. Warning! GuruFocus has detected 6 Warning Signs with PHAT. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Phathom Pharmaceuticals Inc
Show less
Read more
Impact Snapshot
Event Time:
PHAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHAT alerts
High impacting Phathom Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
PHAT
News
- Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdatesGlobeNewswire
- Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]Yahoo! Finance
- Phathom Pharmaceuticals to Participate in Upcoming Investor ConferencesGlobeNewswire
- Investors bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m despite increasing losses YoY, taking one-year return to 96% [Yahoo! Finance]Yahoo! Finance
- Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024GlobeNewswire
PHAT
Earnings
- 11/7/24 - Beat
PHAT
Sec Filings
- 11/12/24 - Form SC
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- PHAT's page on the SEC website